RGEN - Financial Reports List - Repligen Corporation - IntrinsicAlpha

Repligen Corporation RGEN

Healthcare - Medical - Instruments & Supplies - NASDAQ - US

$ 113.17

-8.02 %

$ 6.35 B

Market Cap

-243.35

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	7.58%	-32.88%	-4015.11%
Annual Report	FY	10-K	2024-12-31	0.33%	-71.68%	-73.61%
Quarterly Report	Q3	8-K	2024-09-30	9.69%	-3.60%	-162.90%
Quarterly Report	Q2	8-K	2024-06-30	-3.20%	-83.45%	-92.33%
Quarterly Report	Q1	8-K	2024-03-31	-17.14%	-92.74%	-93.50%
Quarterly Report	Q4	8-K	2023-12-31	-16.61%	-52.31%	-5.00%
Annual Report	FY	10-K	2023-12-31	-21.11%	-80.86%	-64.30%
Quarterly Report	Q3	8-K	2023-09-30	-29.66%	-55.03%	-90.87%
Quarterly Report	Q2	8-K	2023-06-30	-23.34%	-59.76%	-69.29%
Quarterly Report	Q1	8-K	2023-03-31	-11.50%	-38.61%	-47.91%

1